NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE ointment 미국 - 영어 - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates and dexamethasone ointment

direct_rx - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns ; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/enterobacter

TAROCIDIN D 이스라엘 - 영어 - Ministry of Health

tarocidin d

taro pharmaceutical industries ltd - chloramphenicol; dexamethasone sodium phosphate; polymyxin b sulfate - eye drops - chloramphenicol 2 mg/ml; dexamethasone sodium phosphate 0.25 mg/ml; polymyxin b sulfate 2500 u/ml - dexamethasone and antiinfectives - dexamethasone and antiinfectives - for the treatment of serious superficial ocular infections due to strains of microorganisms susceptible to chloramphenicol and/or polymyxin b sulphate.

POLYFAX OINTMENT, 10,000 IU POLYMYXIN B SULPHATE + 500 IU BACITRACIN ZINC. 아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

polyfax ointment, 10,000 iu polymyxin b sulphate + 500 iu bacitracin zinc.

pliva pharma limited - polymyxin b sulfate ; bacitracin zinc - unknown - international unit - bacitracin

Maxitrol 0.1% w/v, 6000 IU/ml, 3500 IU/ml eye drops, suspension 아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

maxitrol 0.1% w/v, 6000 iu/ml, 3500 iu/ml eye drops, suspension

novartis ireland limited - dexamethasone; polymyxin b sulfate; neomycin sulfate - eye drops, suspension - 0.1% w/v, 6000 iu/ml, 3500 iu/ml percent weight/volume - corticosteroids and antiinfectives in combination; dexamethasone and antiinfectives

POLYMYXIN B SULFATE AND TRIMETHOPRIM solution 미국 - 영어 - NLM (National Library of Medicine)

polymyxin b sulfate and trimethoprim solution

direct rx - polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x) - polymyxin b sulfate and trimethoprim ophthalmic solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus epidermidis, streptococcus pneumoniae, streptococcus viridans, haemophilus influenzae and pseudomonas aeruginosa.* *efficacy for this organism in this organ system was studied in fewer than 10 infections. polymyxin b sulfate and trimethoprim ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.

NEO-POLY-DEX- neomycin sulfate, polymyxin b sulfate and dexamethasone suspension/ drops 미국 - 영어 - NLM (National Library of Medicine)

neo-poly-dex- neomycin sulfate, polymyxin b sulfate and dexamethasone suspension/ drops

butler animal health supply - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - neomycin sulfate 3.5 mg in 1 ml - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitis is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/enterobacter sp

NEO-POLY-DEX- neomycin sulfate, polymyxin b sulfate, and dexamethasone ointment 미국 - 영어 - NLM (National Library of Medicine)

neo-poly-dex- neomycin sulfate, polymyxin b sulfate, and dexamethasone ointment

butler animal health supply - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - neomycin sulfate 3.5 mg in 1 g - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain cases of infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drugs in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/ente

POLYMYXIN B SULFATE AND TRIMETHOPRIM solution/ drops 미국 - 영어 - NLM (National Library of Medicine)

polymyxin b sulfate and trimethoprim solution/ drops

preferred pharmaceuticals inc. - polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - polymyxin b 10000 [usp'u] in 1 ml

POLYMYXIN B SULFATE AND TRIMETHOPRIM solution/ drops 미국 - 영어 - NLM (National Library of Medicine)

polymyxin b sulfate and trimethoprim solution/ drops

lake erie medical & surgical supply dba quality care products llc - polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - polymyxin b 10000 [usp'u] in 1 ml

NPD- neomycin sulfate, polymyxin b sulfate, and dexamethasone ointment 미국 - 영어 - NLM (National Library of Medicine)

npd- neomycin sulfate, polymyxin b sulfate, and dexamethasone ointment

phoenix pharmaceutical, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - neomycin sulfate 3.5 mg in 1 g - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain cases of infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drugs in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/ente